- Home
- JACS vs PRTA Comparison
JACS vs PRTA Comparison
Compare JACS & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JACS
- PRTA
- Stock Information
- Founded
- JACS 2024
- PRTA 2012
- Country
- JACS United States
- PRTA Ireland
- Employees
- JACS N/A
- PRTA N/A
- Industry
- JACS
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- JACS
- PRTA Health Care
- Exchange
- JACS NYSE
- PRTA Nasdaq
- Market Cap
- JACS 303.6M
- PRTA 346.4M
- IPO Year
- JACS 2024
- PRTA N/A
- Fundamental
- Price
- JACS $10.33
- PRTA $6.41
- Analyst Decision
- JACS
- PRTA Buy
- Analyst Count
- JACS 0
- PRTA 9
- Target Price
- JACS N/A
- PRTA $27.67
- AVG Volume (30 Days)
- JACS 73.5K
- PRTA 1.7M
- Earning Date
- JACS 01-01-0001
- PRTA 08-07-2025
- Dividend Yield
- JACS N/A
- PRTA N/A
- EPS Growth
- JACS N/A
- PRTA N/A
- EPS
- JACS N/A
- PRTA N/A
- Revenue
- JACS N/A
- PRTA $137,935,000.00
- Revenue This Year
- JACS N/A
- PRTA N/A
- Revenue Next Year
- JACS N/A
- PRTA $122.02
- P/E Ratio
- JACS $267.37
- PRTA N/A
- Revenue Growth
- JACS N/A
- PRTA 54.55
- 52 Week Low
- JACS $9.94
- PRTA $4.32
- 52 Week High
- JACS $10.41
- PRTA $25.42
- Technical
- Relative Strength Index (RSI)
- JACS N/A
- PRTA 57.61
- Support Level
- JACS N/A
- PRTA $5.96
- Resistance Level
- JACS N/A
- PRTA $6.77
- Average True Range (ATR)
- JACS 0.00
- PRTA 0.36
- MACD
- JACS 0.00
- PRTA 0.14
- Stochastic Oscillator
- JACS 0.00
- PRTA 75.80
About JACS JACKSON ACQUISITION COMPANY II
Jackson Acquisition Co II is a newly incorporated blank check company.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.